加拿大某三级癌症中心成人T细胞白血病/淋巴瘤患者的独特特征与社会决定因素
该研究回顾性分析1993—2023年一家加拿大三级癌症中心收治的79例成人T细胞白血病/淋巴瘤(ATLL)患者,中位诊断年龄47岁,72%为加勒比裔。中位无进展生存期10.2个月、总生存期16.2个月,仅5例接受异基因干细胞移植;诊断时中枢神经系统(CNS)受累占22%且与更差结局相关,14%在中位4.9个月内出现CNS复发。安大略边缘化指数显示材料、住房/住所及种族化/新移民相关边缘化程度高于大多伦多地区一般人群,但未与更差结局相关。
要点
- 本队列ATLL患者以加勒比裔为主,诊断年龄偏轻,中位年龄47岁。
- 诊断时CNS受累占22%并与更差结局相关,14%在中位4.9个月内CNS复发。
- 中位无进展生存期10.2个月、总生存期16.2个月,仅5例接受异基因干细胞移植。
核心结论
- 本队列ATLL患者以加勒比裔为主、诊断年龄轻,CNS受累多见且生存结局差,作者认为ATLL是未满足的临床需求。
研究设计与样本
- 回顾性分析1993—2023年在一家加拿大三级癌症中心治疗的79例ATLL患者。
主要发现
- 中位诊断年龄47岁,72%的患者为加勒比裔。
- 中位无进展生存期10.2个月,中位总生存期16.2个月,仅5例接受异基因干细胞移植。
- 诊断时CNS受累占22%并与更差结局相关;14%的患者在中位4.9个月内出现CNS复发。
- 安大略边缘化指数显示材料、住房/住所及种族化/新移民相关边缘化程度高于大多伦多地区一般人群,但这些因素未与更差结局相关。
关键数值与推荐
- 中位无进展生存期10.2个月,中位总生存期16.2个月。
- 诊断时CNS受累22%,CNS复发14%,CNS复发中位时间4.9个月。
- 72%的患者为加勒比裔,中位诊断年龄47岁,79例中5例接受异基因干细胞移植。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adult T-cell leukaemia/lymphoma (ATLL) is a rare, aggressive haematological malignancy linked to human T-cell leukaemia virus type I (HTLV-1) and associated with poor outcomes. Despite its higher prevalence in HTLV-1-endemic regions, the relationship between clinical characteristics and patients' sociocultural background remains underexplored. We retrospectively analysed 79 ATLL patients treated at our institution (1993-2023). The median age at diagnosis was 47 years, and 72% of patients were of Caribbean origin. Median progression-free and overall survival were 10.2 and 16.2 months, respectively, with only five patients receiving allogeneic stem cell transplantation. Central nervous system (CNS) involvement at diagnosis occurred in 22% of patients and was associated with worse outcomes, while 14% experienced CNS relapse within a median of 4.9 months. Using the Ontario Marginalization Index, we found higher levels of material, household/dwelling and racialized/newcomer-related marginalization compared to the general Greater Toronto Area population, though these factors were not linked to poorer outcomes. Our findings reveal that ATLL patients in this cohort were predominantly of Caribbean descent, presented at a young age and faced significant CNS involvement and poor survival outcomes, underscoring ATLL as an unmet clinical need.
引用
- Aoki T, Salib M, Suleman A, et al. Distinct characteristics and social determinants in adult T-cell leukaemia/lymphoma patients at a tertiary cancer centre in Canada. Br J Haematol. 2025. PMID: 40328512. doi:10.1111/bjh.20132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。